We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.2%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43.6B
AUM Growth
+$2.01B
(+4.8%)
Cap. Flow
+$1.75B
Cap. Flow
% of AUM
4%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$674M |
| 2 |
IBM
IBM
|
+$408M |
| 3 |
Toronto Dominion Bank
TD
|
+$392M |
| 4 |
Biogen
BIIB
|
+$340M |
| 5 |
Boeing
BA
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$366M |
| 2 |
CVS Health
CVS
|
+$350M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$333M |
| 4 |
TSMC
TSM
|
+$323M |
| 5 |
Merck
MRK
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
501
DELISTED
Immunogen Inc
IMGN
| $7.26M | 0.02% |
690,445
+428,503
| +164% | +$4.23M |
|
|
TWX
502
DELISTED
Time Warner Inc
TWX
| $7.25M | 0.02% |
+76,600
| New | +$7.22M |
|
503
JB Hunt Transport Services
JBHT
$25.2B
| $7.23M | 0.02% |
61,700
+28,900
| +88% | +$3.46M |
|
504
Integer Holdings
ITGR
$4.26B
| $7.22M | 0.02% |
127,637
+54,040
| +73% | +$2.72M |
|
505
Eaton
ETN
$174B
| $7.18M | 0.02% |
89,800
-466,685
| -84% | -$38.3M |
|
506
Stepan Co
SCL
$1.48B
| $7.13M | 0.02% |
85,767
+1,587
| +2% | +$126K |
|
|
NUAN
507
DELISTED
Nuance Communications, Inc.
NUAN
| $7.13M | 0.02% |
522,609
-132,969
| -20% | -$1.95M |
|
508
Perdoceo Education
PRDO
$2.12B
| $7.11M | 0.02% |
541,232
-1,416
| -0.3% | -$18.1K |
|
509
CAE Inc. Common Shares
CAE
$8.74B
| $7.1M | 0.02% |
381,707
-40,237
| -10% | -$738K |
|
510
MidCap Financial Investment
MFIC
$804M
| $7.05M | 0.02% |
450,458
-477,789
| -51% | -$7.93M |
|
511
Alliance Resource Partners
ARLP
$3.17B
| $7.04M | 0.02% |
398,741
-3,400
| -0.8% | -$64.6K |
|
|
PVLA
512
Palvella Therapeutics
PVLA
$2.27B
| $7.02M | 0.02% |
12,872
+7,292
| +131% | +$4.51M |
|
513
Marvell Technology
MRVL
$196B
| $6.98M | 0.02% |
332,300
-219,971
| -40% | -$5.04M |
|
514
Apple
AAPL
$4.57T
| $6.95M | 0.02% |
165,704
-1,600
| -1% | -$68.9K |
|
|
ZEN
515
DELISTED
ZENDESK INC
ZEN
| $6.81M | 0.02% |
+142,183
| New | +$5.9M |
|
516
W.W. Grainger
GWW
$60.2B
| $6.8M | 0.02% |
+24,100
| New | +$6.31M |
|
|
MGP
517
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $6.78M | 0.02% |
255,552
-93,313
| -27% | -$2.54M |
|
518
Ollie's Bargain Outlet
OLLI
$4.94B
| $6.71M | 0.02% |
111,321
+82,321
| +284% | +$4.68M |
|
519
Monarch Casino & Resort
MCRI
$2.23B
| $6.69M | 0.02% |
158,162
-10,100
| -6% | -$443K |
|
|
CNCE
520
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $6.69M | 0.02% |
291,950
+183,250
| +169% | +$4.08M |
|
521
Galicia Financial Group
GGAL
$7.42B
| $6.67M | 0.02% |
101,365
+62,501
| +161% | +$4.1M |
|
|
MASI
522
DELISTED
Masimo
MASI
| $6.63M | 0.02% |
75,363
-921,710
| -92% | -$80.3M |
|
523
Cohen & Steers
CNS
$4.3B
| $6.58M | 0.02% |
+161,728
| New | +$6.79M |
|
524
Regis Corp
RGS
$70.3M
| $6.55M | 0.02% |
21,651
-748
| -3% | -$236K |
|
525
Kraft Heinz
KHC
$30B
| $6.52M | 0.02% |
104,700
-2,846
| -3% | -$204K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Arrowstreet Capital held 1,493 positions worth $43.6B, up 4.8% from $41.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital deployed $1.75B of net new capital in Q1 2018, opening 278 new positions and adding to 387 existing holdings. Its largest new stake was AB InBev: 2,063,707 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Philip Morris, an estimated $366M trimmed.
- Arrowstreet Capital's largest Q1 2018 buy was AB InBev: 2,063,707 shares worth $227M.
- Arrowstreet Capital added most to AbbVie in Q1 2018, an estimated $674M increase.
- Arrowstreet Capital's biggest Q1 2018 reduction was Philip Morris, cutting an estimated $366M.
- Arrowstreet Capital fully exited iShares MSCI South Korea ETF in Q1 2018, selling an estimated $271M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $43.6B portfolio in Q1 2018.
- Arrowstreet Capital opened 278 new positions and closed 399 in Q1 2018.
- Arrowstreet Capital's portfolio value rose 4.8% quarter-over-quarter to $43.6B.
Based on Arrowstreet Capital's 13F filing for Q1 2018, filed 14 May 2018.